Literature DB >> 15921668

Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia.

Tarak H Patel1, Hideo Kimura, Clifford R Weiss, Gregg L Semenza, Lawrence V Hofmann.   

Abstract

OBJECTIVE: Hypoxia-inducible factor 1 (HIF-1) regulates the expression of angiogenic growth factors. We analyzed the effect of intramuscular (i.m.) delivery of AdCA5, an adenovirus encoding a constitutively active form of the HIF-1alpha subunit, in a novel model of limb ischemia.
METHODS: AdCa5 or AdLacZ (6 x 10(8) pfu) was injected into male New Zealand White rabbits that were untreated or subjected to occlusion of the left superficial femoral artery by endovascular coils. Expression of mRNAs was quantified 1, 3, and 7 days after adenovirus injection into rabbits without occlusion. Calf blood pressure (BP), angiography, and immunohistochemical analyses were performed 14 days after arterial occlusion and adenovirus injection.
RESULTS: AdCA5 increased the expression of HIF-1alpha, monocyte chemotactic protein-1, placental growth factor, platelet-derived growth factor B, stromal-derived factor 1alpha, and vascular endothelial growth factor (VEGF) mRNA as well as HIF-1alpha and VEGF protein. On day 14, AdCA5-injected limbs showed improved calf BP ratios (0.89+/-0.13 vs. 0.51+/-0.05, p=0.02), angiographic perfusion scores (3.50+/-0.56 vs. 8.33+/-1.31, p=0.007), and distal deep femoral artery diameter ratio (1.84+/-0.25 vs. 0.93+/-0.22, p=0.02) relative to those receiving AdLacZ. The capillary/myocyte ratio (0.93+/-0.03 vs. 0.78+/-0.06, p=0.04) and arterial luminal area (0.32+/-0.05 mm2 vs. 0.21+/-0.03 mm2, p=0.04) were significantly increased in the AdCA5 group.
CONCLUSION: In a model that resembles atherosclerotic obstruction of peripheral arteries in patients, the i.m. administration of AdCA5 promoted arteriogenic and angiogenic responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921668     DOI: 10.1016/j.cardiores.2005.05.002

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  45 in total

1.  Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-β signaling.

Authors:  Hong Wei; Djahida Bedja; Norimichi Koitabashi; Dongmei Xing; Jasper Chen; Karen Fox-Talbot; Rosanne Rouf; Shaoping Chen; Charles Steenbergen; John W Harmon; Harry C Dietz; Kathleen L Gabrielson; David A Kass; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-08       Impact factor: 11.205

2.  In vivo remote delivery of DNA encoding for hypoxia-inducible factor 1 alpha reduces myocardial infarct size.

Authors:  Gabor Czibik; Vladimir Martinov; Arno Ruusalepp; Julia Sagave; Øivind Skare; Guro Valen
Journal:  Clin Transl Sci       Date:  2009-02       Impact factor: 4.689

Review 3.  Microvascular repair: post-angiogenesis vascular dynamics.

Authors:  Amanda J LeBlanc; Laxminarayanan Krishnan; Christopher J Sullivan; Stuart K Williams; James B Hoying
Journal:  Microcirculation       Date:  2012-11       Impact factor: 2.628

Review 4.  Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits.

Authors:  Naomi M Hamburg; Gary J Balady
Journal:  Circulation       Date:  2011-01-04       Impact factor: 29.690

5.  X-ray-visible microcapsules containing mesenchymal stem cells improve hind limb perfusion in a rabbit model of peripheral arterial disease.

Authors:  Dorota A Kedziorek; Lawrence V Hofmann; Yingli Fu; Wesley D Gilson; Kenyatta M Cosby; Bernard Kohl; Brad P Barnett; Brian W Simons; Piotr Walczak; Jeff W M Bulte; Kathleen Gabrielson; Dara L Kraitchman
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

6.  Role of HIF-1α in maternal hyperglycemia-induced embryonic vasculopathy.

Authors:  Peixin Yang; E Albert Reece
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

7.  Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis.

Authors:  Kuniko Kimura; Masayuki Iwano; Debra F Higgins; Yukinari Yamaguchi; Kimihiko Nakatani; Koji Harada; Atsushi Kubo; Yasuhiro Akai; Erinn B Rankin; Eric G Neilson; Volker H Haase; Yoshihiko Saito
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

8.  Altered hypoxia-inducible factor-1 alpha expression levels correlate with coronary vessel anomalies.

Authors:  Jamie Wikenheiser; Julie A Wolfram; Madhusudhana Gargesha; Ke Yang; Ganga Karunamuni; David L Wilson; Gregg L Semenza; Faton Agani; Steven A Fisher; Nicole Ward; Michiko Watanabe
Journal:  Dev Dyn       Date:  2009-10       Impact factor: 3.780

Review 9.  Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Authors:  Alejandro R Chade; Nicholas Stewart
Journal:  J Am Soc Hypertens       Date:  2013-02-19

10.  Synergistic effect of HIF-1alpha gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia.

Authors:  Sergio Rey; KangAe Lee; C Joanne Wang; Kshitiz Gupta; Shaoping Chen; Alexandra McMillan; Nupura Bhise; Andre Levchenko; Gregg L Semenza
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.